Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene

Microbiology and Immunology

Volumn 50, Issue 4, 2006, Pages 253-263

  Mussalem, Juliana Sekeres ^a   Vasconcelos, José Ronnie C ^a   Squaiella, Carla Cristina ^a   Ananias, Renata Zeigler ^a   Braga, Eleni Gonçalves ^a   Rodrigues, Maurício M ^a   Longo Maugéri, Ieda Maria ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DNA immunization; Immunomodulation; Propionibacterium acnes; Trypanosoma cruzi

Indexed keywords

BACTERIAL ANTIGEN; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PLASMID DNA; POLYSACCHARIDE; SIALIDASE; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; PROTOZOAL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERIUM; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; EXPERIMENTAL STUDY; FEMALE; GENE TARGETING; GENE THERAPY; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PARASITEMIA; PROPIONIBACTERIUM ACNES; TRYPANOSOMA CRUZI; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BLOOD; CHAGAS DISEASE; CHEMISTRY; CYTOLOGY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; PARASITOLOGY; PLASMID; SPLEEN; TH1 CELL; TH2 CELL;

BACTERIA (MICROORGANISMS); MUS; PROPIONIBACTERIUM ACNES; TRYPANOSOMA CRUZI;

ANIMALS; ANTIBODY SPECIFICITY; CHAGAS DISEASE; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; NEURAMINIDASE; PARASITEMIA; PLASMIDS; POLYSACCHARIDES; PROPIONIBACTERIUM ACNES; PROTOZOAN VACCINES; SPLEEN; TH1 CELLS; TH2 CELLS; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 33745157192     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03791.x     Document Type: Article

References (39)

1. Abath, F.G.C., Coutinho, E.M., Montenegro, S.M.L., Gomes, Y.M., and Carvalho, A.B. 1988. The use of nonspecific immunopotentiators in experimental Trypanosoma cruzi infection. Trans. R. Soc. Trop. Med. Hyg. 82: 73-76.
2. Ananias, R.Z., Braga, E.G., Longhini, A.L.F., Mussalem, J.S., Squaiella, C.C., and Longo-Maugéri, I.M. 2001. In vitro non-specific anti-tumoral activity and surface molecules expression in cells obtained from mice treated with killed Propionibacterium acnes. Scand. J. Immunol. 54 (Suppl 1): 133.
3. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
4. Braga, E.G. 1998. Propionibacterium acnes: imunogenicidade, efeitos sobre atividade fagocítica de macrófagos e resistência ao crescimento tumoral em camundongos [tese]. São Paulo: Universidade Federal de São Paulo-Escola Paulista de Medicina.
5. Braga, E.G., Ananias, R.Z., Mussalem, J.S., Squaiella, C.C., Longhini, A.L.F., Mariano, M., Travassos, L.R., and Longo-Maugéri, I.M. 2003. Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice. Immunol. Lett. 88: 163-169.
6. Brener, Z., and Cardoso, J.E. 1976. Nonspecific resistance against Trypanosoma cruzi enhanced by Corynebacterium parvum. J. Parasitol. 62: 645-646.
7. Cervi, L., MacDonald, A.S., Kane, C., Dzierszinski, F., and Pearce, E.J. 2004. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J. Immunol. 172: 2016-2020.
8. Costa, F., Franchin, G., Pereira-Chioccola, V.L., Ribeirão, M., Schenkman, S., and Rodrigues, M.M. 1998. Immunization with plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16: 768-774.
9. Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., and Smith, F. 1951. A colorimetric method for the determination of sugars. Nature 28: 167.
10. + T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 69: 5477-5486.
11. Halon, L., Argyle, D., Bain, D., Nicolson, L., Dunham, S., Golder, M.C., McDonald, M., McCillivray, C., Jarret, O., Neil, J.C., and Onions, D.E. 2001. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J. Virol. 75: 8424-8433.
12. Halpern, B.N., Biozzi, G., Stiffel, C., and Mouton, D. 1966. Inhibition of tumour growth by administration of killed Corynebacterium parvum. Nature 212: 853-854.
13. Halpern, B.N., Prévot, R., Biozzi, G., Stiffel, C., Mouton, D., Morard, J.C., Bouthillier, Y., and Decreusefond, C. 1963. Stimulation de l'activité phagocytaire du système reticuloendothélial provoquée par Corynebacterium parvum. J. Reticuloendothel. Soc. 1: 77-96.
14. Hölscher, C., Kölher, G., Müller, U., Mossman, H., Schaud, G.A., and Brombacher, F. 1998. Detective nitric oxide effector function lead to extreme susceptibility of Trypanosoma cruzi-infection mice deficient in gamma interferon receptor on inducible nitric oxide synthase. Infect. Immun. 66: 1208-1215.
15. Keller, R., Keist, R., and Joller, P.W. 1994. Macrophage response to bacteria and bacterial products: modulation on Fcγ receptors and secretory and cellular activities. Immunology 81: 161-166.
16. Krettli, A.U., and Brener, Z. 1976. Protective effects of specific antibodies in Trypanosoma cruzi infections. J. Immunol. 116: 755-760.
17. Longhini, A.L.F., Mussalem, J.S., Takahashi, H., Straus, A., and Longo-Maugéri, I.M. 2001. Soluble polysaccharide from Propionibacterium acnes with biological effects. Scand. J. Immunol. 54 (Suppl 1): 90.
18. MacDonald, A.S., Straw, A.D., Bauman, B., and Pearce, E.J. 2001. CD8-dendritic cell activation status plays an integral role in influencing Th2 response development. J. Immunol. 167: 1982-1988.
19. MacDonald, A.S., Straw, A.D., Dalton, N.M., and Pearce, E.J. 2002. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J. Immunol. 168: 537-540.
20. + T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159: 97-106.
21. Min, W., Lillehoj, H.S., Burnside, J., Weining, K.C., Staeheli, P., and Zhu, J.J. 2002. Adjuvant effects of IL-1β, IL-2, IL-8, IL-5, IFN-aα, IFN-γ TGF-β and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine 20: 267-274.
22. Moser, M. 2003. Dendritic cells in immunity and tolerance - do they display opposite functions? Immunity 19: 5-8.
23. Palmer, J.W., and Gerlough, T.D. 1940. Scientific apparatus and laboratory methods. Science 92: 155-156.
24. Peng, H.J., Tsai, L.C., Su, S.N., Chang, Z.N., Shen, H.D., Chao, P.L., Huo, S.W., Tsao, I.Y., and Hung, M.W. 2004. Comparison of different adjuvants of protein and DNA vaccination for the prophylaxis of IgE antibody formation. Vaccine 22: 755-761.
25. Piedrafita, D., Xu, D., Hunter, D., Harrison, R.A., and Liew, F.Y. 1999. Protective immune response induced by vaccination with an expression genomic library of Leishmania major. J. Immunol. 163:1467-1472.
26. Ribeirão, M., Pereira-Chioccola, V.L., Eichinger, D., Rodrigues, M.M., and Schenkman, S. 1997. Temperature differences for trans- glycosilation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Glycobiology 7: 1237-1246.
27. Rodrigues, M.M., Ribeirão, M., Pereira-Chioccola, V.L., Renia, L., and Costa, F. 1999. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with DNA vaccine containing a Trypanosoma cruzi gene. Inf. Immunol. 67: 3855-3863.
28. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, New York.
29. Sin, J.I., Bagarazzi, M., Pachuk, C., and Weiner, D.B. 1999. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model. DNA Cell Biol. 10: 771-779.
30. Siqueira, A.L., Russo, M., Steil, A.A., Facincone, S., Mariano, M., and Jancar, S. 1997. A new murine model of pulmonary eosinophilic hypersensitivity: contribution to experimental asthma. J. Allergy Clin. Immunol. 100: 383-388.
31. Tarleton, R.L., Grusby, M.J., and Zhang, L. 2000. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J. Immunol. 165:1520-1525.
32. Tsuji, H., Mukaida, N., Harada, A., Kaneko, S., Matsushita, E., Nakanuma, Y., Tsutsui, H., Okamura, H., Nakanishi, K., Tagawa, Y., Iwakura, Y., Kobayashi, K., and Matsushima, K. 1999. Alleviation of lipopolysaccharide- induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12 and IL-18 production. J. Immunol. 162: 1049-1055.
33. Vasconcelos, J.R.C., Boscardin, S.B., Hiyane, M.I., Kinoshita, S.S., Fujimura, A.E., and Rodrigues, M.M. 2003. A DNA-priming protein-boosting regimen significant improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Immunol. Cell Biol. 81: 121-129.
34. Warr, G.W., and James, K. 1975. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. Immunology 28: 431-442.
35. Webster, G.F. 1990. Inflammatory acne. Int. J. Dermatol. 29: 313-317.
36. Woodruff, M.F.A., McBride, W.H., and Dunbar, N. 1974. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum treated mice. Clin. Exp. Immunol. 17: 509-518.
37. Xiang, R., Primus, F.J., Ruehlmann, J.M., Niethammer, A.G., Silleti, S., Lode, H.N., Dolman, C.S., Gillies, S.D., and Reisfeld, R.A. 2001. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice. J. Immunol. 167: 4560-4565.
38. Yoneyama, H., Matsuno, K., Zhang, Y., Murai, M., Itakura, M., Ishikawa, S., Hasegawa, G., Naito, M., Asakura, H., and Matsushima, K. 2001. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 193: 35-49.
39. Zhang, Y., Yoneyama, H., Wang, Y., Ishikawa, S., Hashimoto, S., Gao, J.L., Murphy, P., and Matsushima, K. 2004. Mobilization of dendritic cell precursors into the circulation by administration of MIP 1-α in mice. J. Natl. Cancer Inst. 96: 201-209.